{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:25:24Z","timestamp":1778905524180,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-18-0088"],"award-info":[{"award-number":["APVV-18-0088"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010783","name":"Slovensk\u00e1 Akad\u00e9mia Vied","doi-asserted-by":"publisher","award":["VEGA 1\/0255\/20"],"award-info":[{"award-number":["VEGA 1\/0255\/20"]}],"id":[{"id":"10.13039\/100010783","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pyruvate carboxylase (PC) is an enzyme catalyzing the carboxylation of pyruvate to oxaloacetate. The enzymatic generation of oxaloacetate, an intermediate of the Krebs cycle, could provide the cancer cells with the additional anaplerotic capacity and promote their anabolic metabolism. Recent studies revealed that several types of cancer cells express PC. The gained anaplerotic capability of cells mediated by PC correlates with their expedited growth, higher aggressiveness, and increased metastatic potential. By immunohistochemical staining and immunoblotting analysis, we investigated PC expression among samples of different types of human brain tumors. Our results show that PC is expressed by the cells in glioblastoma, astrocytoma, oligodendroglioma, and meningioma tumors. The presence of PC in these tumors suppose that PC could support the anabolic metabolism of their cellular constituents by its anaplerotic capability.<\/jats:p>","DOI":"10.1007\/s11064-023-03856-5","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T07:47:18Z","timestamp":1674200838000},"page":"1728-1736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immunodetection of Pyruvate Carboxylase Expression in Human Astrocytomas, Glioblastomas, Oligodendrogliomas, and Meningiomas"],"prefix":"10.1007","volume":"48","author":[{"given":"Eduard","family":"Gond\u00e1\u0161","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al\u017ebeta","family":"Kr\u00e1\u013eov\u00e1 Tran\u010d\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Dibdiakov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1\u0161","family":"Galanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozef","family":"Hatok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Ra\u010day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Du\u0161an","family":"Dobrota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radovan","family":"Mur\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"3856_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW (2016) The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci 41:211\u2013218. https:\/\/doi.org\/10.1016\/j.tibs.2015.12.001","journal-title":"Trends Biochem Sci"},{"key":"3856_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","volume":"39","author":"KC Patra","year":"2014","unstructured":"Patra KC, Hay N (2014) The pentose phosphate pathway and cancer. Trends Biochem Sci 39:347\u2013354. https:\/\/doi.org\/10.1016\/j.tibs.2014.06.005","journal-title":"Trends Biochem Sci"},{"key":"3856_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s13238-017-0451-1","volume":"9","author":"NM Anderson","year":"2018","unstructured":"Anderson NM, Mucka P, Kern JG, Feng H (2018) The emerging role and targetability of the TCA cycle in cancer metabolism. Protein Cell 9:216\u2013237. https:\/\/doi.org\/10.1007\/s13238-017-0451-1","journal-title":"Protein Cell"},{"key":"3856_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23:27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006","journal-title":"Cell Metab"},{"key":"3856_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.01.007","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB (2022) The hallmarks of cancer metabolism: still emerging. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2022.01.007","journal-title":"Cell Metab"},{"key":"3856_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10545-006-0320-1","volume":"29","author":"H Brunengraber","year":"2006","unstructured":"Brunengraber H, Roe CR (2006) Anaplerotic molecules: current and future. J Inherit Metab Dis 29:327\u2013331. https:\/\/doi.org\/10.1007\/s10545-006-0320-1","journal-title":"J Inherit Metab Dis"},{"key":"3856_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","volume":"35","author":"DR Wise","year":"2010","unstructured":"Wise DR, Thompson CB (2010) Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 35:427\u2013433. https:\/\/doi.org\/10.1016\/j.tibs.2010.05.003","journal-title":"Trends Biochem Sci"},{"key":"3856_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4062\/biomolther.2017.178","volume":"26","author":"Y-K Choi","year":"2018","unstructured":"Choi Y-K, Park K-G (2018) Targeting glutamine metabolism for cancer treatment. Biomol Ther 26:19\u201328. https:\/\/doi.org\/10.4062\/biomolther.2017.178","journal-title":"Biomol Ther"},{"key":"3856_CR9","doi-asserted-by":"publisher","first-page":"19180","DOI":"10.1038\/s41598-019-55718-2","volume":"9","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Zhao X, Chen V et al (2019) Colorectal cancers utilize glutamine as an anaplerotic substrate of the TCA cycle in vivo. Sci Rep 9:19180. https:\/\/doi.org\/10.1038\/s41598-019-55718-2","journal-title":"Sci Rep"},{"key":"3856_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","volume":"3","author":"AA Cluntun","year":"2017","unstructured":"Cluntun AA, Lukey MJ, Cerione RA, Locasale JW (2017) Glutamine metabolism in cancer: understanding the heterogeneity. Trends Cancer 3:169\u2013180. https:\/\/doi.org\/10.1016\/j.trecan.2017.01.005","journal-title":"Trends Cancer"},{"key":"3856_CR11","doi-asserted-by":"publisher","first-page":"8674","DOI":"10.1073\/pnas.1016627108","volume":"108","author":"T Cheng","year":"2011","unstructured":"Cheng T, Sudderth J, Yang C et al (2011) Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proc Natl Acad Sci 108:8674\u20138679. https:\/\/doi.org\/10.1073\/pnas.1016627108","journal-title":"Proc Natl Acad Sci"},{"key":"3856_CR12","doi-asserted-by":"publisher","first-page":"e0129848","DOI":"10.1371\/journal.pone.0129848","volume":"10","author":"P Phannasil","year":"2015","unstructured":"Phannasil P, Thuwajit C, Warnnissorn M et al (2015) Pyruvate carboxylase is up-regulated in breast cancer and essential to support growth and invasion of MDA-MB-231 cells. PLoS ONE 10:e0129848. https:\/\/doi.org\/10.1371\/journal.pone.0129848","journal-title":"PLoS ONE"},{"key":"3856_CR13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1172\/JCI72873","volume":"125","author":"K Sellers","year":"2015","unstructured":"Sellers K, Fox MP, Bousamra M et al (2015) Pyruvate carboxylase is critical for non\u2013small-cell lung cancer proliferation. J Clin Invest 125:687\u2013698. https:\/\/doi.org\/10.1172\/JCI72873","journal-title":"J Clin Invest"},{"key":"3856_CR14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.celrep.2016.09.042","volume":"17","author":"S Christen","year":"2016","unstructured":"Christen S, Lorendeau D, Schmieder R et al (2016) Breast cancer-derived lung metastases show increased pyruvate carboxylase-dependent anaplerosis. Cell Rep 17:837\u2013848. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.042","journal-title":"Cell Rep"},{"key":"3856_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.bbadis.2016.11.021","volume":"1863","author":"P Phannasil","year":"2017","unstructured":"Phannasil P, Ansari IH, El Azzouny M et al (2017) Mass spectrometry analysis shows the biosynthetic pathways supported by pyruvate carboxylase in highly invasive breast cancer cells. Biochim Biophys Acta BBA - Mol Basis Dis 1863:537\u2013551. https:\/\/doi.org\/10.1016\/j.bbadis.2016.11.021","journal-title":"Biochim Biophys Acta BBA - Mol Basis Dis"},{"key":"3856_CR16","doi-asserted-by":"publisher","first-page":"1903483","DOI":"10.1002\/advs.201903483","volume":"7","author":"Q Lin","year":"2020","unstructured":"Lin Q, He Y, Wang X et al (2020) Targeting pyruvate carboxylase by a small molecule suppresses breast cancer progression. Adv Sci 7:1903483. https:\/\/doi.org\/10.1002\/advs.201903483","journal-title":"Adv Sci"},{"key":"3856_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4149\/gpb_2021003","volume":"40","author":"E Gond\u00e1\u0161","year":"2021","unstructured":"Gond\u00e1\u0161 E, Kr\u00e1\u013eov\u00e1 Tran\u010d\u00edkov\u00e1 A, Majer\u010d\u00edkov\u00e1 Z et al (2021) Expression of pyruvate carboxylase in cultured human astrocytoma, glioblastoma and neuroblastoma cells. Gen Physiol Biophys 40:127\u2013135. https:\/\/doi.org\/10.4149\/gpb_2021003","journal-title":"Gen Physiol Biophys"},{"key":"3856_CR18","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20080709","author":"S Jitrapakdee","year":"2008","unstructured":"Jitrapakdee S, Maurice MST, Rayment I et al (2008) Structure, mechanism and regulation of pyruvate carboxylase. Biochem J. https:\/\/doi.org\/10.1042\/BJ20080709","journal-title":"Biochem J"},{"key":"3856_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40170-021-00256-7","volume":"9","author":"VA Kiesel","year":"2021","unstructured":"Kiesel VA, Sheeley MP, Coleman MF et al (2021) Pyruvate carboxylase and cancer progression. Cancer Metab 9:20. https:\/\/doi.org\/10.1186\/s40170-021-00256-7","journal-title":"Cancer Metab"},{"key":"3856_CR20","doi-asserted-by":"publisher","first-page":"30409","DOI":"10.1074\/jbc.R200006200","volume":"277","author":"OE Owen","year":"2002","unstructured":"Owen OE, Kalhan SC, Hanson RW (2002) The key role of anaplerosis and cataplerosis for citric acid cycle function. J Biol Chem 277:30409\u201330412. https:\/\/doi.org\/10.1074\/jbc.R200006200","journal-title":"J Biol Chem"},{"key":"3856_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ceb.2015.02.003","volume":"33","author":"L Shi","year":"2015","unstructured":"Shi L, Tu BP (2015) Acetyl-CoA and the regulation of metabolism: mechanisms and consequences. Curr Opin Cell Biol 33:125\u2013131. https:\/\/doi.org\/10.1016\/j.ceb.2015.02.003","journal-title":"Curr Opin Cell Biol"},{"key":"3856_CR22","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1002\/iub.2367","volume":"72","author":"P Borst","year":"2020","unstructured":"Borst P (2020) The malate-aspartate shuttle (Borst cycle): how it started and developed into a major metabolic pathway. IUBMB Life 72:2241\u20132259. https:\/\/doi.org\/10.1002\/iub.2367","journal-title":"IUBMB Life"},{"key":"3856_CR23","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3389\/fendo.2018.00802","volume":"9","author":"X Zhang","year":"2018","unstructured":"Zhang X, Yang S, Chen J, Su Z (2018) Unraveling the regulation of hepatic gluconeogenesis. Front Endocrinol 9:802. https:\/\/doi.org\/10.3389\/fendo.2018.00802","journal-title":"Front Endocrinol"},{"key":"3856_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.canlet.2017.09.045","volume":"411","author":"T Wilmanski","year":"2017","unstructured":"Wilmanski T, Zhou X, Zheng W et al (2017) Inhibition of pyruvate carboxylase by 1\u03b1,25-dihydroxyvitamin D promotes oxidative stress in early breast cancer progression. Cancer Lett 411:171\u2013181. https:\/\/doi.org\/10.1016\/j.canlet.2017.09.045","journal-title":"Cancer Lett"},{"key":"3856_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13058-018-1008-9","volume":"20","author":"A Shinde","year":"2018","unstructured":"Shinde A, Wilmanski T, Chen H et al (2018) Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer. Breast Cancer Res 20:76. https:\/\/doi.org\/10.1186\/s13058-018-1008-9","journal-title":"Breast Cancer Res"},{"key":"3856_CR26","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1046\/j.1471-4159.1995.64052312.x","volume":"64","author":"M Cesar","year":"1995","unstructured":"Cesar M, Hamprecht B (1995) Immunocytochemical examination of neural rat and mouse primary cultures using monoclonal antibodies raised against pyruvate carboxylase. J Neurochem 64:2312\u20132318. https:\/\/doi.org\/10.1046\/j.1471-4159.1995.64052312.x","journal-title":"J Neurochem"},{"key":"3856_CR27","doi-asserted-by":"publisher","first-page":"32606","DOI":"10.1038\/srep32606","volume":"6","author":"NM Cetinbas","year":"2016","unstructured":"Cetinbas NM, Sudderth J, Harris RC et al (2016) Glucose-dependent anaplerosis in cancer cells is required for cellular redox balance in the absence of glutamine. Sci Rep 6:32606. https:\/\/doi.org\/10.1038\/srep32606","journal-title":"Sci Rep"},{"key":"3856_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11060-015-1978-8","volume":"126","author":"J Tichy","year":"2016","unstructured":"Tichy J, Spechtmeyer S, Mittelbronn M et al (2016) Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma. J Neurooncol 126:361\u2013369. https:\/\/doi.org\/10.1007\/s11060-015-1978-8","journal-title":"J Neurooncol"},{"key":"3856_CR29","doi-asserted-by":"publisher","first-page":"6285","DOI":"10.21873\/anticanres.14649","volume":"40","author":"J Ngamkham","year":"2020","unstructured":"Ngamkham J, Thuwajit C, Thuwajit P et al (2020) Overexpression of pyruvate carboxylase is correlated with colorectal cancer progression and supports growth of invasive colon cancer HT-29 cell line. Anticancer Res 40:6285\u20136293. https:\/\/doi.org\/10.21873\/anticanres.14649","journal-title":"Anticancer Res"},{"key":"3856_CR30","doi-asserted-by":"publisher","first-page":"e56782","DOI":"10.7554\/eLife.56782","volume":"9","author":"AN Lau","year":"2020","unstructured":"Lau AN, Li Z, Danai LV et al (2020) Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma. Elife 9:e56782. https:\/\/doi.org\/10.7554\/eLife.56782","journal-title":"Elife"},{"key":"3856_CR31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4149\/BLL_2022_077","volume":"123","author":"E Gondas","year":"2022","unstructured":"Gondas E, Hives M, Kliment J et al (2022) The ubiquitous expression of pyruvate carboxylase among human prostate tumors. Bratisl Med J 123:487\u2013490. https:\/\/doi.org\/10.4149\/BLL_2022_077","journal-title":"Bratisl Med J"},{"key":"3856_CR32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cmet.2012.05.001","volume":"15","author":"I Marin-Valencia","year":"2012","unstructured":"Marin-Valencia I, Yang C, Mashimo T et al (2012) Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab 15:827\u2013837. https:\/\/doi.org\/10.1016\/j.cmet.2012.05.001","journal-title":"Cell Metab"},{"key":"3856_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev-nutr-120420-025558","volume":"41","author":"M Inigo","year":"2021","unstructured":"Inigo M, Deja S, Burgess SC (2021) Ins and outs of the TCA cycle: the central role of anaplerosis. Annu Rev Nutr 41:19\u201347. https:\/\/doi.org\/10.1146\/annurev-nutr-120420-025558","journal-title":"Annu Rev Nutr"},{"key":"3856_CR34","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/iub.2149","volume":"71","author":"E Baranovi\u010dov\u00e1","year":"2019","unstructured":"Baranovi\u010dov\u00e1 E, Galanda T, Galanda M et al (2019) Metabolomic profiling of blood plasma in patients with primary brain tumours: basal plasma metabolites correlated with tumour grade and plasma biomarker analysis predicts feasibility of the successful statistical discrimination from healthy subjects - a preliminary study. IUBMB Life 71:1994\u20132002. https:\/\/doi.org\/10.1002\/iub.2149","journal-title":"IUBMB Life"},{"key":"3856_CR35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1042\/BJ20080709","volume":"413","author":"S Jitrapakdee","year":"2008","unstructured":"Jitrapakdee S, St Maurice M, Rayment I et al (2008) Structure, mechanism and regulation of pyruvate carboxylase. Biochem J 413:369\u2013387. https:\/\/doi.org\/10.1042\/BJ20080709","journal-title":"Biochem J"},{"key":"3856_CR36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrd3504","volume":"10","author":"MG Vander Heiden","year":"2011","unstructured":"Vander Heiden MG (2011) Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov 10:671\u2013684. https:\/\/doi.org\/10.1038\/nrd3504","journal-title":"Nat Rev Drug Discov"},{"key":"3856_CR37","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol (Berl) 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol (Berl)"},{"key":"3856_CR38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/cancers14030585","volume":"14","author":"E Gond\u00e1\u0161","year":"2022","unstructured":"Gond\u00e1\u0161 E, Kr\u00e1\u013eov\u00e1 Tran\u010d\u00edkov\u00e1 A, Baranovi\u010dov\u00e1 E et al (2022) Expression of 3-methylcrotonyl-CoA carboxylase in brain tumors and capability to catabolize leucine by human neural cancer cells. Cancers 14:585. https:\/\/doi.org\/10.3390\/cancers14030585","journal-title":"Cancers"},{"key":"3856_CR39","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680\u2013685. https:\/\/doi.org\/10.1038\/227680a0","journal-title":"Nature"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-03856-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-023-03856-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-03856-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T03:43:22Z","timestamp":1682048602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-023-03856-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3856"],"URL":"https:\/\/doi.org\/10.1007\/s11064-023-03856-5","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]},"assertion":[{"value":"8 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}